Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ian Douglas
UBS
Ian Douglas
UBS
Wall Street Analyst
★★★★☆
#286
on 13Foresight · ranked by our own returns
80%
Success Rate
+25.8%
Average Return
4 of 5 calls profitable · +16.4% vs benchmark
📈 Across the calls we could measure, roughly 80% of Ian Douglas's ratings turned a profit when each position was held for 1 year — averaging +25.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

35 Buy 25 Hold 4 Sell
Ian's Stock Coverage 21 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
GB:RR
Rolls-Royce Holdings
 Apr 30, 2026 BUY Strong Buy
-23.8% avg upside
22 analysts
$1400.00
0.57% Downside
 ·
DE:MTX
MTU Aero Engines
 Apr 24, 2026 SELL Buy
+3.4% avg upside
25 analysts
$275.00
17.32% Downside
 ·
FR:SAF
SAFRAN SA
 Apr 23, 2026 HOLD Strong Buy
-13.3% avg upside
24 analysts
$335.00
1.66% Upside
 ·
SE:SAAB.B
Saab AB
 Apr 10, 2026 BUY Buy
-13.9% avg upside
8 analysts
$780.00
55.03% Upside
 ·
IT:LDO
Leonardo Spa
 Apr 10, 2026 HOLD Strong Buy
-1.7% avg upside
11 analysts
$64.00
21.49% Upside
 ·
GB:MRO
Melrose
 Apr 10, 2026 SELL Buy
+34.2% avg upside
11 analysts
$430.00
8.63% Downside
 ·
FR:AIR
Airbus Group SE
 Apr 10, 2026 BUY Strong Buy
-3.9% avg upside
31 analysts
$210.00
10.81% Upside
 ·
GB:BA
BAE Systems
 Apr 10, 2026 BUY Buy
+151.4% avg upside
20 analysts
$2650.00
43.51% Upside
 ·
NL:THEON
Theon International Plc
 Apr 10, 2026 BUY Strong Buy
+23.7% avg upside
3 analysts
$45.00
30.97% Upside
 ·
FR:HO
Thales
 Apr 10, 2026 BUY Strong Buy
-1.1% avg upside
19 analysts
$390.00
67.77% Upside
 ·
FR:AM
Dassault Aviation
 Jan 09, 2026 HOLD Buy
+39.0% avg upside
15 analysts
$330.00
9.33% Upside
 ·
RYCEY
Rolls-Royce
 Mar 21, 2024 BUY Hold
-61.2% avg upside
6 analysts
$7.28
61.18% Downside
 +99.8%
DE:FME
Fresenius Medical Care AG & Co. KGaA
 Jun 27, 2019 BUY Buy
+27.6% avg upside
21 analysts
$92.00
125.95% Upside
 ·
DE:FRE
Fresenius SE & Co. KGaA
 May 09, 2019 HOLD Strong Buy
+29.4% avg upside
19 analysts
$46.00
16.18% Upside
 ·
NL:PHIA
Koninklijke Philips N.V.
 Apr 29, 2019 BUY Buy
+31.4% avg upside
20 analysts
$39.00
65.89% Upside
 ·
CH:ALC
Alcon
 Apr 09, 2019 HOLD Buy
+33.9% avg upside
35 analysts
$57.00
7.81% Upside
 ·
GRFS
Grifols SA
 Apr 01, 2019 SELL Buy
+247.6% avg upside
12 analysts
$20.66
179.23% Upside
 +1.5%
ES:GRF
Grifols
 Apr 01, 2019 SELL Buy
+64.4% avg upside
12 analysts
$18.00
97.83% Upside
 ·
FSNUY
Fresenius SE & Co
 Jan 09, 2019 HOLD Strong Buy
-11.2% avg upside
6 analysts
 — +13.4%
FMS
Fresenius Medical Care
 Oct 26, 2018 BUY Buy
+97.2% avg upside
13 analysts
 — -16.8%
SNN
Smith & Nephew Snats
 Aug 08, 2018 HOLD Buy
+11.8% avg upside
14 analysts
 — +31.2%
🔒 16 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ian Douglas — Frequently Asked Questions
How accurate are Ian Douglas's stock ratings?
Based on the calls 13Foresight could measure, about 80% of Ian's ratings were profitable over a one-year hold, with an average return of +25.8% per rating, or +16.4% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ian ranked on 13Foresight?
Ian Douglas is currently ranked #286 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ian cover?
Ian most recently has ratings on GB:RR, DE:MTX, FR:SAF, SE:SAAB.B, IT:LDO, GB:MRO, FR:AIR, GB:BA, NL:THEON, FR:HO, FR:AM, RYCEY and 9 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.